Last updated July, 3 2014 639.049 documents processed, 16.613.935 references and 6.218.529 citations

PharmacoEconomics / Springer

[Raw data] [Main indicators] [Most cited papers] [cites used to compute the impact factor] [Recent citations ][documents published in EconPapers] [Keep updated about new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw data:

IF AIF DOC CDO CCU CIF CIT D2Y C2Y %SC CiY II AII
19900.09000000.04
19910.09000000.04
19920.09000000.04
19930.1000000.05
19940.11000000.05
19950.2000000.08
19960.24000000.1
19970.38800000.11
19980.29122001800.11
19990.342040.202000.15
20000.4220001200.16
20010.4432300000.17
20020.452300300.2
20030.4752800300.2
20040.5312900500.22
20050.5673610.032600.23
20060.556298014800.22
20070.030.473813620.01569200.19
20080.5221580910000.21
20090.5128186016000.21
20100.020.473321930.01350100.17
20110.553024940.02561010.030.22
20120.050.6787336120.04263333.310.010.26
20130.030.9296432240.0612117333.3100.10.34
20140.010.686149370.01018321000.24
 
 
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CCU: Cumulative number of citations to papers published until year y
CIF: Cumulative impact factor
CIT: Number of citations to papers published in year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y

 

Most cited documents in this series:

YearTitleCited
2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

8
2006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

4
2008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

4
2011Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

3
2006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25.

Full description at Econpapers || Download paper

3
2008Assessing the Impact of Global Price Interdependencies. (2008). Richter, Anke . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:649-659.

Full description at Econpapers || Download paper

2
2005Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. (2005). Briggs, Andrew ; Grossman, Ronald ; Spencer, Michael ; Rance, Laureen . In: PharmacoEconomics. RePEc:spr:pharme:v:23:y:2005:i:6:p:619-637.

Full description at Econpapers || Download paper

2
2006The Impact of Therapeutic Reference Pricing on Innovation in Cardiovascular Medicine. (2006). SHERIDAN, DESMOND ; ATTRIDGE, JIM. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:35-54.

Full description at Econpapers || Download paper

2
2010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:11:p:987-993.

Full description at Econpapers || Download paper

2
1998Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma. (1998). Doorslaer, Eddy ; Molken, Maureen ; Till, M.. In: PharmacoEconomics. RePEc:spr:pharme:v:14:y:1998:i:6:p:671-684.

Full description at Econpapers || Download paper

1
2008Future Drug Prices and Cost-Effectiveness Analyses. (2008). Hoyle, Martin . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:589-602.

Full description at Econpapers || Download paper

1
2011Availability of and Access to Orphan Drugs. (2011). Stargardt, Tom ; Schreyögg, Jonas ; Blankart, Carl ; Schreyogg, Jonas . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:63-82.

Full description at Econpapers || Download paper

1
2006Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries. (2006). Brezin, Antoine ; Mimaud, Viviane ; Lopatriello, Stefania ; Hieke, Klaus ; Hutchinson, Julia ; Berdeaux, Gilles ; Lafuma, Antoine . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:193-205.

Full description at Econpapers || Download paper

1
2007Do Drugs Reduce Utilisation of Other Healthcare Resources?. (2007). Petit, Patrick ; Ouellette, Pierre ; Cremieux, Pierre-Yves . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:3:p:209-221.

Full description at Econpapers || Download paper

1
2009Cost Effectiveness in Low- and Middle-Income Countries. (2009). Mills, Anne ; Shillcutt, Samuel ; Walker, Damian ; Goodman, Catherine . In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917.

Full description at Econpapers || Download paper

1
2013What Evidence Is There for the Reimbursement of Personalised Medicine?. (2013). McCabe, Christopher ; Hall, Peter . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:3:p:181-183.

Full description at Econpapers || Download paper

1
2006The Value of Thinly Spread QALYs. (2006). Mortimer, Duncan . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:845-853.

Full description at Econpapers || Download paper

1
2008Cost-Effectiveness Analyses of Vaccination Programmes. (2008). Goldie, Sue ; Kim, Sun-Young . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:3:p:191-215.

Full description at Econpapers || Download paper

1
2006Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain. (2006). Bagust, Adrian ; Escolano, Isabel Perez ; Paris, Gonzalo ; Ampudia-Blasco, F. ; alvarez, Belen Martinez-Lage ; Shearer, Arran . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:1:p:49-59.

Full description at Econpapers || Download paper

1
2013Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?. (2013). McCabe, Christopher ; Hall, Peter ; Edlin, Richard . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:731-737.

Full description at Econpapers || Download paper

1
2007Measuring Preferences for Cost-Utility Analysis. (2007). Tosteson, Anna ; McDonough, Christine . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:2:p:93-106.

Full description at Econpapers || Download paper

1
2012A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease. (2012). Leidl, Reiner ; Menn, Petra ; Holle, Rolf . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:9:p:825-840.

Full description at Econpapers || Download paper

1
2008Cost-Effectiveness Analyses of Hepatitis A Vaccine. (2008). Anonychuk, Andrea ; Gilca, Vladimir ; Krahn, Murray ; Woo, Gloria ; Bauch, Chris ; Duval, Bernard ; Pham, Ba ; John-Baptiste, Ava ; Tricco, Andrea . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:1:p:17-32.

Full description at Econpapers || Download paper

1
2010The State of Health Economic Evaluation Research in Nigeria. (2010). Oladapo, Abiola ; Khoza, Star ; Gavaza, Paul ; Rascati, Karen . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:7:p:539-553.

Full description at Econpapers || Download paper

1
2006Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies. (2006). Birks, Stuart . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1273-1274.

Full description at Econpapers || Download paper

1
2013Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities. (2013). McCabe, Christopher ; Kharroubi, Samer ; Brown, Chantelle ; Meads, David ; Edlin, Richard . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:635-641.

Full description at Econpapers || Download paper

1
2007Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants. (2007). Hout, Hein ; Stalman, Wim ; Brook, Oscar ; Tulder, Maurits ; Bruijne, Martine ; Bouter, Lex ; Bosmans, Judith ; Nieuwenhuyse, Hugo . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:1:p:25-37.

Full description at Econpapers || Download paper

1
2012Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:219-227.

Full description at Econpapers || Download paper

1
2006The Impact of Incremental Innovation in Biopharmaceuticals. (2006). Cockburn, Iain ; Berndt, Ernst ; Grepin, Karen . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:69-86.

Full description at Econpapers || Download paper

1
2007Direct and Indirect Costs Attributable to Alcohol Consumption in Germany. (2007). Konnopka, Alexander ; Konig, Hans-Helmut . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:7:p:605-618.

Full description at Econpapers || Download paper

1
2010Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. (2010). Salkeld, Glenn ; Kelly, Patrick ; Stockler, Martin ; Chim, Lesley . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:6:p:463-475.

Full description at Econpapers || Download paper

1
2013The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies. (2013). Miraldo, Marisa ; McGrath, Clare ; Camejo, Rodrigo Refoios ; Rutten, Frans . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:445-454.

Full description at Econpapers || Download paper

1
2007Economic Evidence at the Local Level. (2007). Viney, Rosalie ; Haas, Marion ; Hall, Jane ; Gallego, Gisselle ; Ward, Robyn ; Gool, Kees . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:12:p:1055-1062.

Full description at Econpapers || Download paper

1
2008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

1
2011Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV. (2011). Galarraga, Omar ; Figueroa-Lara, Alejandro ; Yared Santa-Ana-Tellez, ; Wirtz, Veronika ; Viisainen, Kirsi ; Coulibaly, Ibrahima ; Korenromp, Eline ; Medina-Lara, Antonieta . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:579-599.

Full description at Econpapers || Download paper

1
2007Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients. (2007). Dirksen, Carmen ; Leeuw, Peter ; Nelemans, Patricia ; Prins, Martin ; Joore, Manuela ; Severens, Johan ; Schouten, Jan ; Stoffers, Henri ; Wetzels, Gwenn ; Brunenberg, Danielle . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:3:p:239-251.

Full description at Econpapers || Download paper

1

Citing documents used to compute impact factor 2:

YearTitleSee
2014A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. (2014). Hatz, Maximilian ; Stollenwerk, Bjorn ; Yates, Nichola ; Leidl, Reiner . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:377-393.

Full description at Econpapers || Download paper

[Citation Analysis]
2014Treating Idiopathic Pulmonary Fibrosis with the Addition of Co-Trimoxazole: An Economic Evaluation Alongside a Randomised Controlled Trial. (2014). Wilson, Edward ; Twentyman, Orion ; Clark, Allan ; Parfrey, Helen ; Chilvers, Edwin ; Cahn, Anthony ; Shulgina, Ludmila . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:87-99.

Full description at Econpapers || Download paper

[Citation Analysis]

Cites in year: CiY

Recent citations received in: 2013

YearTitleSee
2013Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab. (2013). Leopold, C. ; Espin, J. ; Mantel-Teeuwisse, A. K. ; Habl, C. ; Vogler, S.. In: Health Policy. RePEc:eee:hepoli:v:113:y:2013:i:3:p:313-322.

Full description at Econpapers || Download paper

[Citation Analysis]
2013Leasing health technologies- an affordable and effective reimbursement strategy for innovative technologies?. (2013). McCabe, Christopher ; Wallner, Klemens ; Hall, Peter ; Edlin, Richard . In: Working Papers. RePEc:lee:wpaper:1302.

Full description at Econpapers || Download paper

[Citation Analysis]
2013Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from Eortic QLQ Data in Myeloma for Use in Cost effectiveness Analysis. (2013). McCabe, Christopher ; Kharroubi, Samer A ; Brown, Julia ; Browne, Chantelle ; Meads, David ; Edlin, Richard . In: Working Papers. RePEc:lee:wpaper:1308.

Full description at Econpapers || Download paper

[Citation Analysis]
2013An Overview of the Health Economic Implications of Elective Caesarean Section. (2013). Petrou, Stavros ; Khan, Kamran . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:11:y:2013:i:6:p:561-576.

Full description at Econpapers || Download paper

[Citation Analysis]
2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:14:y:2013:i:3:p:367-372.

Full description at Econpapers || Download paper

[Citation Analysis]
2013The Road Not Taken: Transferability Issues in Multinational Trials. (2013). Vemer, Pepijn ; Molken, Maureen Rutten-van . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:10:p:863-876.

Full description at Econpapers || Download paper

[Citation Analysis]
2013Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US. (2013). Hellinger, Fred . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1091-1104.

Full description at Econpapers || Download paper

[Citation Analysis]
2013How Much Should the NHS Pay for a QALY?. (2013). Haycox, Alan . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:357-359.

Full description at Econpapers || Download paper

[Citation Analysis]
2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

[Citation Analysis]
2013Good Practice Guidelines for the use of Statistical Regression Models in Economic Evaluations. (2013). Kearns, Ben ; Campbell, Mike ; Abrams, Keith ; Alava, Monica ; Manca, Andrea ; Wailoo, Allan ; Ara, Roberta . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:643-652.

Full description at Econpapers || Download paper

[Citation Analysis]

Recent citations received in: 2012

YearTitleSee
2012The Authors’ Reply. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:980-980.

Full description at Econpapers || Download paper

[Citation Analysis]

Recent citations received in: 2011

YearTitleSee
2011Competition and the Reference Pricing Scheme for pharmaceuticals. (2011). Ghislandi, Simone . In: Journal of Health Economics. RePEc:eee:jhecon:v:30:y:2011:i:6:p:1137-1149.

Full description at Econpapers || Download paper

[Citation Analysis]

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.